Accolade (ACCD) Financials

$7.02 0.00 (0.00%)

As of 04/8/2025

Annual Income Statements for Accolade

This table shows Accolade's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	2/28/2022	2/28/2023	2/29/2024
Net Income / (Loss) Attributable to Common Shareholders	-123	-460	-100
Consolidated Net Income / (Loss)	-123	-460	-100
Net Income / (Loss) Continuing Operations	-123	-460	-100
Total Pre-Tax Income	-129	-463	-99
Total Operating Income	-126	-464	-114
Total Gross Profit	141	164	192
Total Revenue	310	363	414
Operating Revenue	310	363	414
Total Cost of Revenue	169	199	222
Operating Cost of Revenue	169	199	222
Total Operating Expenses	267	628	307
Selling, General & Admin Expense	99	81	62
Marketing Expense	87	99	100
Depreciation Expense	43	46	45
Other Operating Expenses / (Income)	84	101	99
Impairment Charge	0.00	300	0.00
Other Special Charges / (Income)	-45	0.00	0.00
Total Other Income / (Expense), net	-3.04	0.24	16
Interest & Investment Income	-2.91	0.26	5.95
Other Income / (Expense), net	-0.13	-0.02	9.93
Income Tax Expense	-5.64	-3.62	1.24
Basic Earnings per Share	($1.93)	($6.45)	($1.33)
Weighted Average Basic Shares Outstanding	63.82M	71.28M	74.91M
Diluted Earnings per Share	($1.93)	($6.45)	($1.33)
Weighted Average Diluted Shares Outstanding	63.82M	71.28M	74.91M
Weighted Average Basic & Diluted Shares Outstanding	67.29M	73.63M	78.36M

This table shows Accolade's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	5/31/2022	8/31/2022	11/30/2022	2/28/2023	5/31/2023	8/31/2023	11/30/2023	2/29/2024	5/31/2024	8/31/2024	11/30/2024
Net Income / (Loss) Attributable to Common Shareholders	-343	-47	-40	-30	-38	-33	-21	-7.51	-28	-24	-121
Consolidated Net Income / (Loss)	-343	-47	-40	-30	-38	-33	-21	-7.51	-28	-24	-121
Net Income / (Loss) Continuing Operations	-343	-47	-40	-30	-38	-33	-21	-7.51	-28	-24	-121
Total Pre-Tax Income	-347	-46	-40	-30	-38	-33	-21	-6.78	-27	-24	-121
Total Operating Income	-346	-46	-40	-31	-40	-35	-32	-7.90	-29	-25	-122
Total Gross Profit	38	38	41	48	39	42	45	67	52	49	46
Total Revenue	86	88	91	99	93	97	99	125	110	106	105
Operating Revenue	86	88	91	99	93	97	99	125	110	106	105
Total Cost of Revenue	48	50	50	51	54	55	55	58	59	57	59
Operating Cost of Revenue	48	50	50	51	54	55	55	58	59	57	59
Total Operating Expenses	384	84	81	79	79	77	77	75	81	75	169
Selling, General & Admin Expense	20	21	20	20	16	16	15	14	16	17	16
Marketing Expense	26	25	25	24	25	24	26	25	28	25	26
Depreciation Expense	12	12	12	12	12	11	11	11	10	11	10
Other Operating Expenses / (Income)	27	26	24	24	26	26	23	24	26	22	21
Impairment Charge	300	0.00	0.00	-	-	-	0.00	-	-	-	96
Total Other Income / (Expense), net	-0.68	-0.37	0.59	0.70	1.31	2.47	11	1.12	1.79	1.58	1.38
Interest & Investment Income	-0.63	-0.24	0.39	0.74	0.92	1.71	1.71	1.61	1.70	1.69	1.45
Other Income / (Expense), net	-0.05	-0.13	0.20	-0.04	0.39	0.75	9.28	-0.49	0.09	-0.10	-0.07
Income Tax Expense	-3.90	0.25	0.08	-0.05	0.09	0.08	0.33	0.73	0.34	0.37	0.33
Basic Earnings per Share	($4.92)	($0.66)	($0.56)	($0.31)	($0.52)	($0.43)	($0.28)	($0.10)	($0.35)	($0.30)	($1.50)
Weighted Average Basic Shares Outstanding	69.74M	70.48M	71.23M	71.28M	73.18M	75.49M	76.14M	74.91M	78.12M	80.07M	80.65M
Diluted Earnings per Share	($4.92)	($0.66)	($0.56)	($0.31)	($0.52)	($0.43)	($0.28)	($0.53)	($0.35)	($0.30)	($1.50)
Weighted Average Diluted Shares Outstanding	69.74M	70.48M	71.23M	71.28M	73.18M	75.49M	76.14M	74.91M	78.12M	80.07M	80.65M
Weighted Average Basic & Diluted Shares Outstanding	71.21M	71.94M	72.79M	73.63M	75.63M	76.23M	77.41M	78.36M	80.01M	80.54M	81.59M

This table details how cash moves in and out of Accolade's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	2/28/2022	2/28/2023	2/29/2024
Net Change in Cash & Equivalents	-68	-45	-135
Net Cash From Operating Activities	-62	-41	-16
Net Cash From Continuing Operating Activities	-62	-41	-16
Net Income / (Loss) Continuing Operations	-123	-460	-100
Consolidated Net Income / (Loss)	-123	-460	-100
Depreciation Expense	43	46	45
Amortization Expense	2.95	3.70	5.22
Non-Cash Adjustments To Reconcile Net Income	63	378	52
Changes in Operating Assets and Liabilities, net	-48	-9.25	-19
Net Cash From Investing Activities	-264	-7.23	-64
Net Cash From Continuing Investing Activities	-264	-7.23	-64
Purchase of Property, Plant & Equipment	-3.62	-7.23	-12
Acquisitions	-260	0.00	0.00
Purchase of Investments	-100	0.00	-51
Sale and/or Maturity of Investments	100	0.00	0.00
Net Cash From Financing Activities	258	3.16	-56
Net Cash From Continuing Financing Activities	258	3.16	-56
Repayment of Debt	-8.37	0.00	-66
Repurchase of Common Equity	-0.06	0.00	0.00
Issuance of Debt	288	0.00	0.00
Issuance of Common Equity	4.70	2.93	3.58
Other Financing Activities, net	-26	0.24	7.02
Cash Interest Paid	0.93	1.64	1.64
Cash Income Taxes Paid	0.12	0.16	0.40

This table details how cash moves in and out of Accolade's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	5/31/2022	8/31/2022	11/30/2022	2/28/2023	5/31/2023	8/31/2023	11/30/2023	2/29/2024	5/31/2024	8/31/2024	11/30/2024
Net Change in Cash & Equivalents	-30	-5.00	-5.00	-4.55	-18	-11	-62	-44	2.99	-15	13
Net Cash From Operating Activities	-30	-2.99	-4.69	-2.56	-19	-8.04	5.21	5.95	-7.12	4.14	-9.73
Net Cash From Continuing Operating Activities	-30	-2.99	-4.69	-2.56	-19	-8.04	5.21	5.95	-7.12	4.14	-9.73
Net Income / (Loss) Continuing Operations	-343	-47	-40	-30	-38	-33	-21	-7.51	-28	-24	-121
Consolidated Net Income / (Loss)	-343	-47	-40	-30	-38	-33	-21	-7.51	-28	-24	-121
Depreciation Expense	12	12	12	12	12	11	11	11	10	11	10
Amortization Expense	0.82	0.90	0.88	1.11	1.12	1.25	1.64	1.21	0.81	0.72	0.95
Non-Cash Adjustments To Reconcile Net Income	322	16	25	16	15	17	6.53	13	16	14	101
Changes in Operating Assets and Liabilities, net	-22	15	-2.04	-0.59	-8.75	-4.39	6.70	-13	-6.34	2.25	-0.81
Net Cash From Investing Activities	-1.27	-1.63	-1.91	-2.41	-3.38	-3.29	-3.71	-53	8.05	-20	21
Net Cash From Continuing Investing Activities	-1.27	-1.63	-1.91	-2.41	-3.38	-3.29	-3.71	-53	8.05	-20	21
Purchase of Property, Plant & Equipment	-1.27	-1.63	-1.91	-2.41	-3.38	-3.29	-3.71	-2.11	-1.96	-1.05	-0.87
Purchase of Investments	-	-	-	-	-	-	-	-	-	-	-4.92
Sale and/or Maturity of Investments	-	-	-	-	0.00	-	-	-	10	18	27
Net Cash From Financing Activities	1.51	-0.37	1.61	0.42	4.45	0.64	-64	3.00	2.07	0.01	1.14
Net Cash From Continuing Financing Activities	1.51	-0.37	1.61	0.42	4.45	0.64	-64	3.00	2.07	0.01	1.14
Issuance of Common Equity	1.15	0.64	1.14	-	1.99	-	1.59	-	1.94	-	1.14
Other Financing Activities, net	0.36	-1.01	0.47	0.42	2.46	0.64	0.91	3.00	0.12	0.01	0.00
Cash Interest Paid	0.77	0.05	0.72	0.10	0.77	0.05	0.77	0.05	0.58	0.07	0.60
Cash Income Taxes Paid	0.02	-	0.08	0.05	0.05	0.25	0.02	0.08	0.83	0.62	-1.04

This table presents Accolade's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	2/28/2022	2/28/2023	2/29/2024
Total Assets	1,286	903	788
Total Current Assets	409	366	285
Cash & Equivalents	366	321	186
Short-Term Investments	-	0.00	51
Accounts Receivable	31	27	28
Prepaid Expenses	9.47	14	16
Other Current Assets	3.02	4.02	4.37
Plant, Property, & Equipment, net	12	15	19
Total Noncurrent Assets	865	522	484
Goodwill	578	278	278
Intangible Assets	245	203	165
Other Noncurrent Operating Assets	42	41	41
Total Liabilities & Shareholders' Equity	1,286	903	788
Total Liabilities	430	429	343
Total Current Liabilities	112	119	108
Accounts Payable	19	22	24
Current Deferred Revenue	31	35	35
Current Employee Benefit Liabilities	39	39	23
Other Current Liabilities	23	23	25
Total Noncurrent Liabilities	318	310	235
Long-Term Debt	281	282	208
Noncurrent Deferred Revenue	0.27	0.15	0.12
Other Noncurrent Operating Liabilities	37	27	26
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	856	474	445
Total Preferred & Common Equity	856	474	445
Total Common Equity	856	474	445
Common Stock	1,350	1,428	1,500
Retained Earnings	-495	-954	-1,054
Accumulated Other Comprehensive Income / (Loss)	-	0.00	-0.05

This table presents Accolade's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	5/31/2022	8/31/2022	11/30/2022	5/31/2023	8/31/2023	11/30/2023	5/31/2024	8/31/2024	11/30/2024
Total Assets	944	932	914	876	854	785	767	756	647
Total Current Assets	378	375	366	348	336	272	275	275	272
Cash & Equivalents	336	331	326	303	292	230	189	173	186
Short-Term Investments	-	-	-	-	-	-	42	61	40
Accounts Receivable	28	31	24	26	25	26	28	25	31
Prepaid Expenses	10	10	12	15	14	12	13	11	12
Other Current Assets	3.18	3.45	4.08	3.93	4.47	4.46	4.25	4.30	4.21
Plant, Property, & Equipment, net	12	12	14	17	18	19	20	19	19
Total Noncurrent Assets	555	545	534	511	500	494	472	462	356
Goodwill	278	278	278	278	278	278	278	278	182
Intangible Assets	234	224	214	193	184	175	157	148	139
Other Noncurrent Operating Assets	43	42	42	40	38	41	38	37	35
Total Liabilities & Shareholders' Equity	944	932	914	876	854	785	767	756	647
Total Liabilities	410	425	428	422	417	351	332	333	334
Total Current Liabilities	95	113	117	113	109	116	98	101	104
Accounts Payable	18	21	21	19	20	21	19	20	21
Current Deferred Revenue	37	45	44	44	48	53	39	41	38
Current Employee Benefit Liabilities	23	31	35	28	25	26	22	27	33
Other Current Liabilities	18	16	17	22	16	16	18	13	11
Total Noncurrent Liabilities	314	313	311	309	308	235	234	232	231
Long-Term Debt	281	282	282	283	283	208	209	209	209
Noncurrent Deferred Revenue	0.28	0.28	0.26	0.14	0.10	0.12	0.10	0.09	0.07
Other Noncurrent Operating Liabilities	33	31	29	26	24	0.17	25	23	21
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	535	506	486	454	438	435	435	423	313
Total Preferred & Common Equity	535	506	486	454	438	435	435	423	313
Total Common Equity	535	506	486	454	438	435	435	423	313
Common Stock	1,372	1,390	1,410	1,447	1,463	1,481	1,517	1,529	1,540
Retained Earnings	-837	-884	-924	-993	-1,026	-1,047	-1,082	-1,106	-1,227
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	-	-0.03	0.03	0.02

This table displays calculated financial ratios and metrics derived from Accolade's official financial filings.

Metric	2022	2023	2024
Period end date	2/28/2022	2/28/2023	2/29/2024
Growth Metrics	-	-	-
Revenue Growth	81.98%	17.13%	14.09%
EBITDA Growth	-116.72%	-414.85%	86.91%
EBIT Growth	-168.22%	-268.30%	77.45%
NOPAT Growth	-168.78%	-268.67%	75.31%
Net Income Growth	-143.08%	-273.32%	78.29%
EPS Growth	-12.21%	-234.20%	79.38%
Operating Cash Flow Growth	-147.11%	34.72%	60.28%
Free Cash Flow Firm Growth	-3,437.01%	101.23%	-657.54%
Invested Capital Growth	1,890.61%	-43.55%	-4.16%
Revenue Q/Q Growth	12.53%	1.47%	6.64%
EBITDA Q/Q Growth	-23.20%	-0.29%	29.47%
EBIT Q/Q Growth	-25.01%	-0.28%	17.93%
NOPAT Q/Q Growth	-24.88%	-0.30%	16.91%
Net Income Q/Q Growth	-31.97%	0.89%	18.68%
EPS Q/Q Growth	0.00%	1.83%	-19.82%
Operating Cash Flow Q/Q Growth	-25.53%	-0.68%	34.48%
Free Cash Flow Firm Q/Q Growth	-1.69%	-43.93%	33.82%
Invested Capital Q/Q Growth	-1.90%	-1.63%	-5.14%
Profitability Metrics	-	-	-
Gross Margin	45.48%	45.23%	46.36%
EBITDA Margin	-25.90%	-113.85%	-13.07%
Operating Margin	-40.55%	-127.64%	-27.63%
EBIT Margin	-40.60%	-127.64%	-25.23%
Profit (Net Income) Margin	-39.71%	-126.58%	-24.09%
Tax Burden Percent	95.62%	99.22%	101.25%
Interest Burden Percent	102.31%	99.95%	94.31%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-24.19%	-53.82%	-18.81%
ROIC Less NNEP Spread (ROIC-NNEP)	-10.66%	164.32%	39.69%
Return on Net Nonoperating Assets (RNNOA)	4.44%	-15.32%	-2.91%
Return on Equity (ROE)	-19.75%	-69.14%	-21.71%
Cash Return on Invested Capital (CROIC)	-117.01%	1.84%	-14.56%
Operating Return on Assets (OROA)	-14.29%	-42.36%	-12.36%
Return on Assets (ROA)	-13.98%	-42.00%	-11.80%
Return on Common Equity (ROCE)	-19.75%	-69.14%	-21.71%
Return on Equity Simple (ROE_SIMPLE)	-14.39%	-97.02%	-22.40%
Net Operating Profit after Tax (NOPAT)	-88	-324	-80
NOPAT Margin	-28.39%	-89.35%	-19.34%
Net Nonoperating Expense Percent (NNEP)	-13.53%	-218.14%	-58.50%
Cost of Revenue to Revenue	54.52%	54.77%	53.64%
SG&A Expenses to Revenue	31.97%	22.36%	15.00%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	86.04%	172.87%	73.98%
Earnings before Interest and Taxes (EBIT)	-126	-464	-105
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-80	-413	-54
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.41	1.71	1.78
Price to Tangible Book Value (P/TBV)	36.25	0.00	424.97
Price to Revenue (P/Rev)	3.88	2.23	1.92
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.45	1.77	1.83
Enterprise Value to Revenue (EV/Rev)	3.61	2.12	1.85
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	69.23	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.33	0.60	0.47
Long-Term Debt to Equity	0.33	0.60	0.47
Financial Leverage	-0.42	-0.09	-0.07
Leverage Ratio	1.41	1.65	1.84
Compound Leverage Factor	1.45	1.65	1.74
Debt to Total Capital	24.70%	37.34%	31.88%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	24.70%	37.34%	31.88%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	75.30%	62.66%	68.12%
Debt to EBITDA	-3.50	-0.68	-3.85
Net Debt to EBITDA	1.06	0.09	0.53
Long-Term Debt to EBITDA	-3.50	-0.68	-3.85
Debt to NOPAT	-3.19	-0.87	-2.60
Net Debt to NOPAT	0.97	0.12	0.36
Long-Term Debt to NOPAT	-3.19	-0.87	-2.60
Altman Z-Score	1.34	-1.31	-0.13
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	3.66	3.06	2.64
Quick Ratio	3.55	2.91	2.45
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-902	11	-62
Operating Cash Flow to CapEx	-1,723.80%	-563.16%	-129.54%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.35	0.33	0.49
Accounts Receivable Turnover	14.54	12.63	15.23
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	29.49	27.35	24.44
Accounts Payable Turnover	10.68	9.77	9.58
Days Sales Outstanding (DSO)	25.10	28.90	23.96
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	34.16	37.38	38.09
Cash Conversion Cycle (CCC)	-9.06	-8.48	-14.13
Capital & Investment Metrics	-	-	-
Invested Capital	771	435	417
Invested Capital Turnover	0.85	0.60	0.97
Increase / (Decrease) in Invested Capital	814	-336	-18
Enterprise Value (EV)	1,119	770	765
Market Capitalization	1,204	809	793
Book Value per Share	$12.78	$6.51	$5.75
Tangible Book Value per Share	$0.50	($0.10)	$0.02
Total Capital	1,136	756	654
Total Debt	281	282	208
Total Long-Term Debt	281	282	208
Net Debt	-85	-39	-29
Capital Expenditures (CapEx)	3.62	7.23	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-68	-75	-60
Debt-free Net Working Capital (DFNWC)	297	247	177
Net Working Capital (NWC)	297	247	177
Net Nonoperating Expense (NNE)	35	135	20
Net Nonoperating Obligations (NNO)	-85	-39	-29
Total Depreciation and Amortization (D&A)	46	50	50
Debt-free, Cash-free Net Working Capital to Revenue	-22.09%	-20.53%	-14.48%
Debt-free Net Working Capital to Revenue	95.92%	67.89%	42.74%
Net Working Capital to Revenue	95.92%	67.89%	42.74%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($1.93)	($6.45)	($1.33)
Adjusted Weighted Average Basic Shares Outstanding	63.82M	71.28M	74.91M
Adjusted Diluted Earnings per Share	($1.93)	($6.45)	($1.33)
Adjusted Weighted Average Diluted Shares Outstanding	63.82M	71.28M	74.91M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	67.29M	73.63M	78.36M
Normalized Net Operating Profit after Tax (NOPAT)	-120	-115	-80
Normalized NOPAT Margin	-38.64%	-31.58%	-19.34%
Pre Tax Income Margin	-41.53%	-127.57%	-23.79%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.05%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Accolade's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	5/31/2022	8/31/2022	11/30/2022	2/28/2023	5/31/2023	8/31/2023	11/30/2023	2/29/2024	5/31/2024	8/31/2024	11/30/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	43.68%	19.59%	8.98%	5.62%	9.00%	10.52%	9.26%	26.06%	18.49%	9.80%	5.73%
EBITDA Growth	-760.66%	46.52%	-171.92%	-7.01%	92.06%	33.32%	66.09%	122.32%	32.98%	37.95%	-1,085.68%
EBIT Growth	-619.96%	38.15%	-251.22%	-4.33%	88.66%	25.16%	44.16%	73.13%	26.21%	26.72%	-445.43%
NOPAT Growth	-620.69%	38.33%	-222.22%	-4.61%	88.55%	23.31%	21.45%	74.68%	26.70%	28.58%	-285.62%
Net Income Growth	-603.85%	25.40%	-277.19%	11.93%	88.80%	29.44%	47.17%	75.33%	28.16%	27.09%	-475.69%
EPS Growth	-485.71%	31.96%	-280.65%	27.91%	89.43%	34.85%	50.00%	-70.97%	32.69%	30.23%	-435.71%
Operating Cash Flow Growth	-10.31%	72.86%	78.10%	-12.04%	36.68%	-168.56%	210.93%	332.55%	63.08%	151.56%	-287.01%
Free Cash Flow Firm Growth	23.33%	133.28%	139.73%	137.60%	105.43%	-98.56%	-106.18%	-95.99%	-98.39%	220.34%	392.48%
Invested Capital Growth	27.21%	-40.95%	-43.71%	-43.55%	-9.67%	-6.29%	-0.62%	-4.16%	-4.75%	-7.19%	-32.44%
Revenue Q/Q Growth	-8.78%	2.47%	3.77%	8.88%	-5.86%	3.90%	2.59%	25.62%	-11.51%	-3.72%	-1.22%
EBITDA Q/Q Growth	-1,831.32%	89.94%	17.49%	33.25%	-43.24%	15.47%	58.03%	143.92%	-530.17%	21.75%	-701.95%
EBIT Q/Q Growth	-1,056.48%	86.70%	12.72%	22.29%	-25.67%	12.19%	34.88%	62.61%	-245.10%	12.80%	-384.75%
NOPAT Q/Q Growth	-1,060.73%	86.73%	12.04%	22.77%	-27.07%	11.16%	9.91%	75.10%	-267.84%	13.44%	-386.46%
Net Income Q/Q Growth	-892.08%	86.43%	14.30%	23.67%	-26.21%	14.54%	35.83%	64.36%	-267.55%	13.26%	-406.66%
EPS Q/Q Growth	-1,044.19%	86.59%	15.15%	44.64%	-67.74%	17.31%	34.88%	-89.29%	33.96%	14.29%	-400.00%
Operating Cash Flow Q/Q Growth	-1,233.67%	90.17%	-56.77%	45.46%	-653.69%	58.32%	164.75%	14.33%	-219.64%	158.20%	-334.89%
Free Cash Flow Firm Q/Q Growth	58.66%	182.64%	10.51%	-0.42%	-94.03%	-78.01%	-572.72%	164.62%	-97.60%	4,278.30%	331.61%
Invested Capital Q/Q Growth	-37.64%	-4.82%	-3.31%	-1.63%	-0.22%	-1.25%	2.54%	-5.14%	-0.84%	-3.77%	-25.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.33%	43.14%	44.57%	48.45%	41.86%	42.89%	45.14%	53.38%	46.94%	46.48%	44.25%
EBITDA Margin	-390.16%	-38.30%	-30.46%	-18.67%	-28.41%	-23.11%	-9.45%	3.31%	-16.07%	-13.06%	-106.02%
Operating Margin	-404.59%	-52.38%	-44.40%	-31.49%	-42.51%	-36.35%	-31.92%	-6.33%	-26.30%	-23.64%	-116.42%
EBIT Margin	-404.65%	-52.53%	-44.18%	-31.53%	-42.09%	-35.57%	-22.58%	-6.72%	-26.21%	-23.74%	-116.49%
Profit (Net Income) Margin	-400.83%	-53.08%	-43.84%	-30.73%	-41.20%	-33.89%	-21.20%	-6.01%	-24.98%	-22.50%	-115.42%
Tax Burden Percent	98.88%	100.54%	100.19%	99.83%	100.24%	100.26%	101.60%	110.76%	101.23%	101.59%	100.27%
Interest Burden Percent	100.18%	100.51%	99.04%	97.63%	97.65%	95.03%	92.40%	80.79%	94.14%	93.32%	98.81%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-221.76%	-20.86%	-18.12%	-13.28%	-24.13%	-21.83%	-19.69%	-4.31%	-18.75%	-17.66%	-98.87%
ROIC Less NNEP Spread (ROIC-NNEP)	-44.26%	344.77%	31.41%	0.60%	4.66%	6.40%	-25.54%	1.57%	15.84%	19.29%	532.27%
Return on Net Nonoperating Assets (RNNOA)	5.16%	-2.19%	-1.15%	-0.06%	-0.35%	-0.39%	1.08%	-0.12%	-0.75%	-0.77%	-8.04%
Return on Equity (ROE)	-216.60%	-23.04%	-19.27%	-13.34%	-24.48%	-22.22%	-18.61%	-4.42%	-19.49%	-18.43%	-106.91%
Cash Return on Invested Capital (CROIC)	-93.07%	6.59%	3.23%	1.84%	-13.89%	-16.64%	-21.25%	-14.56%	-12.29%	-8.44%	3.66%
Operating Return on Assets (OROA)	-148.12%	-16.72%	-14.52%	-10.46%	-17.15%	-15.14%	-10.32%	-3.29%	-13.77%	-13.00%	-72.63%
Return on Assets (ROA)	-146.72%	-16.90%	-14.41%	-10.20%	-16.79%	-14.42%	-9.69%	-2.95%	-13.12%	-12.33%	-71.97%
Return on Common Equity (ROCE)	-216.60%	-23.04%	-19.27%	-13.34%	-24.48%	-22.22%	-18.61%	-4.42%	-19.49%	-18.43%	-106.91%
Return on Equity Simple (ROE_SIMPLE)	-78.06%	-79.28%	-95.44%	0.00%	-34.18%	-32.34%	-28.23%	0.00%	-20.44%	-18.93%	-57.60%
Net Operating Profit after Tax (NOPAT)	-242	-32	-28	-22	-28	-25	-22	-5.53	-20	-18	-86
NOPAT Margin	-283.21%	-36.67%	-31.08%	-22.05%	-29.76%	-25.44%	-22.34%	-4.43%	-18.41%	-16.55%	-81.50%
Net Nonoperating Expense Percent (NNEP)	-177.50%	-365.63%	-49.53%	-13.88%	-28.79%	-28.23%	5.85%	-5.88%	-34.58%	-36.95%	-631.14%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-3.32%	-	-	-	-16.39%
Cost of Revenue to Revenue	55.67%	56.86%	55.43%	51.55%	58.14%	57.11%	54.86%	46.62%	53.06%	53.52%	55.75%
SG&A Expenses to Revenue	23.66%	23.98%	22.03%	20.11%	17.25%	16.79%	15.57%	11.46%	14.49%	15.55%	15.42%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	448.92%	95.53%	88.97%	79.94%	84.37%	79.24%	77.06%	59.71%	73.24%	70.12%	160.67%
Earnings before Interest and Taxes (EBIT)	-346	-46	-40	-31	-39	-34	-22	-8.39	-29	-25	-122
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-334	-34	-28	-18	-26	-22	-9.39	4.13	-18	-14	-111
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.81	1.43	1.31	1.71	1.95	2.33	1.53	1.78	1.27	0.82	0.99
Price to Tangible Book Value (P/TBV)	19.64	173.55	0.00	0.00	0.00	0.00	0.00	424.97	1,008.67	0.00	0.00
Price to Revenue (P/Rev)	1.29	2.07	1.78	2.23	2.39	2.68	1.71	1.92	1.29	0.79	0.70
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.79	1.48	1.34	1.77	2.00	2.36	1.53	1.83	1.29	0.81	0.99
Enterprise Value to Revenue (EV/Rev)	1.12	1.93	1.65	2.12	2.34	2.66	1.73	1.85	1.23	0.73	0.66
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	39.36	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	16.65	29.82	69.23	0.00	0.00	0.00	0.00	0.00	0.00	21.85
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.53	0.56	0.58	0.60	0.62	0.65	0.54	0.47	0.48	0.49	0.67
Long-Term Debt to Equity	0.53	0.56	0.58	0.60	0.62	0.65	0.54	0.47	0.48	0.49	0.67
Financial Leverage	-0.12	-0.01	-0.04	-0.09	-0.08	-0.06	-0.04	-0.07	-0.05	-0.04	-0.02
Leverage Ratio	1.89	1.78	1.71	1.65	1.84	1.89	1.85	1.84	1.85	1.87	1.92
Compound Leverage Factor	1.89	1.78	1.69	1.61	1.80	1.80	1.71	1.49	1.74	1.75	1.89
Debt to Total Capital	34.46%	35.73%	36.71%	37.34%	38.37%	39.28%	35.07%	31.88%	32.42%	33.08%	40.08%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	34.46%	35.73%	36.71%	37.34%	38.37%	39.28%	35.07%	31.88%	32.42%	33.08%	40.08%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	65.54%	64.27%	63.29%	62.66%	61.63%	60.72%	64.93%	68.12%	67.58%	66.92%	59.92%
Debt to EBITDA	-0.75	-0.81	-0.68	-0.68	-2.66	-2.98	-3.06	-3.85	-4.60	-5.67	-1.51
Net Debt to EBITDA	0.15	0.14	0.11	0.09	0.19	0.09	-0.06	0.53	0.48	0.68	0.12
Long-Term Debt to EBITDA	-0.75	-0.81	-0.68	-0.68	-2.66	-2.98	-3.06	-3.85	-4.60	-5.67	-1.51
Debt to NOPAT	-0.95	-1.02	-0.87	-0.87	-2.57	-2.76	-2.44	-2.60	-2.87	-3.18	-1.62
Net Debt to NOPAT	0.18	0.18	0.14	0.12	0.18	0.09	-0.05	0.36	0.30	0.38	0.12
Long-Term Debt to NOPAT	-0.95	-1.02	-0.87	-0.87	-2.57	-2.76	-2.44	-2.60	-2.87	-3.18	-1.62
Altman Z-Score	-1.10	0.24	0.05	0.27	0.27	0.42	-0.09	0.28	-0.26	-0.67	-1.72
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.95	3.33	3.14	3.06	3.09	3.08	2.35	2.64	2.80	2.72	2.63
Quick Ratio	3.81	3.21	3.00	2.91	2.92	2.91	2.21	2.45	2.62	2.57	2.47
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-345	285	315	314	19	4.12	-19	13	0.30	13	57
Operating Cash Flow to CapEx	-2,394.73%	-183.39%	-245.53%	-106.05%	-571.13%	-244.61%	140.22%	282.44%	-364.19%	395.04%	-1,115.01%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.37	0.32	0.33	0.33	0.41	0.43	0.46	0.49	0.53	0.55	0.62
Accounts Receivable Turnover	14.45	14.21	14.29	12.63	13.54	13.59	15.62	15.23	15.98	17.46	15.88
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	27.98	28.62	28.04	27.35	26.05	25.23	23.70	24.44	23.80	24.00	23.64
Accounts Payable Turnover	14.68	12.53	14.31	9.77	11.18	10.37	10.24	9.58	11.79	11.37	11.09
Days Sales Outstanding (DSO)	25.26	25.69	25.54	28.90	26.96	26.85	23.37	23.96	22.84	20.91	22.98
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	24.86	29.13	25.51	37.38	32.65	35.20	35.65	38.09	30.96	32.09	32.90
Cash Conversion Cycle (CCC)	0.40	-3.44	0.04	-8.48	-5.69	-8.35	-12.28	-14.13	-8.12	-11.18	-9.92
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	481	457	442	435	434	429	440	417	413	398	297
Invested Capital Turnover	0.78	0.57	0.58	0.60	0.81	0.86	0.88	0.97	1.02	1.07	1.21
Increase / (Decrease) in Invested Capital	103	-317	-343	-336	-46	-29	-2.73	-18	-21	-31	-143
Enterprise Value (EV)	377	676	591	770	866	1,011	670	765	533	322	295
Market Capitalization	432	725	635	809	887	1,020	666	793	555	347	311
Book Value per Share	$7.94	$7.11	$6.76	$6.51	$6.17	$5.79	$5.70	$5.75	$5.55	$5.29	$3.89
Tangible Book Value per Share	$0.33	$0.06	($0.08)	($0.10)	($0.23)	($0.32)	($0.24)	$0.02	$0.01	($0.03)	($0.10)
Total Capital	816	788	768	756	737	721	670	654	644	632	522
Total Debt	281	282	282	282	283	283	235	208	209	209	209
Total Long-Term Debt	281	282	282	282	283	283	235	208	209	209	209
Net Debt	-55	-49	-44	-39	-20	-9.03	4.78	-29	-22	-25	-16
Capital Expenditures (CapEx)	1.27	1.63	1.91	2.41	3.38	3.29	3.71	2.11	1.96	1.05	0.87
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-54	-69	-76	-75	-67	-65	-74	-60	-54	-61	-57
Debt-free Net Working Capital (DFNWC)	282	262	250	247	236	227	156	177	177	174	169
Net Working Capital (NWC)	282	262	250	247	236	227	156	177	177	174	169
Net Nonoperating Expense (NNE)	101	14	12	8.60	11	8.18	-1.14	1.98	7.26	6.33	36
Net Nonoperating Obligations (NNO)	-54	-49	-44	-39	-20	-9.03	4.78	-29	-22	-25	-16
Total Depreciation and Amortization (D&A)	12	12	12	13	13	12	13	13	11	11	11
Debt-free, Cash-free Net Working Capital to Revenue	-15.93%	-19.55%	-21.24%	-20.53%	-18.10%	-17.08%	-18.94%	-14.48%	-12.47%	-13.75%	-12.67%
Debt-free Net Working Capital to Revenue	83.95%	74.81%	69.75%	67.89%	63.57%	59.80%	40.26%	42.74%	40.97%	39.39%	37.80%
Net Working Capital to Revenue	83.95%	74.81%	69.75%	67.89%	63.57%	59.80%	40.26%	42.74%	40.97%	39.39%	37.80%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($4.92)	($0.66)	($0.56)	($0.31)	($0.52)	($0.43)	($0.28)	($0.10)	($0.35)	($0.30)	($1.50)
Adjusted Weighted Average Basic Shares Outstanding	69.74M	70.48M	71.23M	71.28M	73.18M	75.49M	76.14M	74.91M	78.12M	80.07M	80.65M
Adjusted Diluted Earnings per Share	($4.92)	($0.66)	($0.56)	($0.31)	($0.52)	$0.00	($0.28)	($0.53)	($0.35)	($0.30)	($1.50)
Adjusted Weighted Average Diluted Shares Outstanding	69.74M	70.48M	71.23M	71.28M	73.18M	0.00	76.14M	74.91M	78.12M	80.07M	80.65M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	71.21M	71.94M	72.79M	73.63M	75.63M	76.23M	77.41M	78.36M	80.01M	80.54M	81.59M
Normalized Net Operating Profit after Tax (NOPAT)	-32	-32	-28	-22	-28	-25	-22	-5.53	-20	-18	-18
Normalized NOPAT Margin	-37.92%	-36.67%	-31.08%	-22.05%	-29.76%	-25.44%	-22.34%	-4.43%	-18.41%	-16.55%	-17.23%
Pre Tax Income Margin	-405.39%	-52.80%	-43.76%	-30.78%	-41.10%	-33.80%	-20.86%	-5.43%	-24.67%	-22.15%	-115.11%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Accolade's Financials

When does Accolade's financial year end?

According to the most recent income statement we have on file, Accolade's fiscal year ends in February. Their fiscal year 2024 ended on February 29, 2024.

How has Accolade's net income changed over the last 2 years?

Accolade's net income appears to be on a downward trend, with a most recent value of -$99.81 million in 2024, falling from -$123.12 million in 2022. The previous period was -$459.65 million in 2023. See where experts think Accolade is headed by visiting Accolade's forecast page.

What is Accolade's operating income?

Accolade's total operating income in 2024 was -$114.45 million, based on the following breakdown:

Total Gross Profit: $192.06 million
Total Operating Expenses: $306.51 million

How has Accolade's revenue changed over the last 2 years?

Over the last 2 years, Accolade's total revenue changed from $310.02 million in 2022 to $414.29 million in 2024, a change of 33.6%.

How much debt does Accolade have?

Accolade's total liabilities were at $342.69 million at the end of 2024, a 20.2% decrease from 2023, and a 20.3% decrease since 2022.

How much cash does Accolade have?

In the past 2 years, Accolade's cash and equivalents has ranged from $185.72 million in 2024 to $365.85 million in 2022, and is currently $185.72 million as of their latest financial filing in 2024.

How has Accolade's book value per share changed over the last 2 years?

Over the last 2 years, Accolade's book value per share changed from 12.78 in 2022 to 5.75 in 2024, a change of -55.0%.

Related Companies

This page (NASDAQ:ACCD) was last updated on 6/17/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Accolade (ACCD) Financials

Frequently Asked Questions About Accolade's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Accolade (ACCD) Financials

Annual Income Statements for Accolade

Quarterly Income Statements for Accolade

Annual Cash Flow Statements for Accolade

Quarterly Cash Flow Statements for Accolade

Annual Balance Sheets for Accolade

Quarterly Balance Sheets for Accolade

Annual Metrics And Ratios for Accolade

Quarterly Metrics And Ratios for Accolade

Frequently Asked Questions About Accolade's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools